We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Annals of Pharmacy Practice and Pharmacotherapy

2025 Volume 5

Safety and Efficacy of Laparoscopic Resections in Stage IV Colorectal Cancer: Ensuring a Smooth Postoperative Course and Optimal Pharmacotherapy Outcomes


, ,
  1. Department of Pharmaceutical Chemistry, Technical University of Munich, Garching, Germany.
Abstract

In patients with stage IV colorectal cancer, removing the primary tumor may prevent future tumor-related complications, enhance quality of life, and reduce the likelihood of emergency colostomies. Laparoscopic surgery offers a minimally invasive alternative that can potentially lower perioperative risks in this high-risk patient group. This study evaluates short-term surgical outcomes in 17 patients with stage IV colorectal cancer who had unresectable liver metastases and/or pulmonary or peritoneal metastases. Delays in chemotherapy due to postoperative complications remain a significant concern affecting survival. A retrospective review was conducted on 17 patients who underwent laparoscopic palliative colorectal surgery. Data were collected on perioperative complications, hospital stay duration, intraoperative blood loss, transfusion needs, operative time, and type of procedure performed.

Laparoscopic surgery included 10 sigmoid resections, five left colectomies, and two right colectomies. Fourteen patients also underwent liver biopsies during the same procedure. No deaths or perioperative complications were reported, yielding a 0% mortality and morbidity rate. The median hospital stay was 5.3 days, the median blood loss was 47.9 mL, and a total of three units of blood were transfused (median 0.17 units per patient). The median operative time was 130.2 minutes. Laparoscopic palliative resection in stage IV colorectal cancer is associated with excellent early outcomes, minimal surgical trauma, and rapid recovery, allowing timely initiation of postoperative chemotherapy.


How to cite this article
Vancouver
Müller M, Fischer L, Hoffmann P. Safety and Efficacy of Laparoscopic Resections in Stage IV Colorectal Cancer: Ensuring a Smooth Postoperative Course and Optimal Pharmacotherapy Outcomes. Ann Pharm Pract Pharmacother. 2025;5:88-93. https://doi.org/10.51847/ivZeXlCTmP
APA
Müller, M., Fischer, L., & Hoffmann, P. (2025). Safety and Efficacy of Laparoscopic Resections in Stage IV Colorectal Cancer: Ensuring a Smooth Postoperative Course and Optimal Pharmacotherapy Outcomes. Annals of Pharmacy Practice and Pharmacotherapy, 5, 88-93. https://doi.org/10.51847/ivZeXlCTmP
Articles
Therapeutic Approaches to Facilitating Expulsion of Distal Ureteric Stones
Annals of Pharmacy Practice and Pharmacotherapy
Vol 2 , 2022 | Ravindra Ambardekar
Evaluation of Antidiabetic Drug Prescribing Practices in Primary Care Clinics in Rural South India
Annals of Pharmacy Practice and Pharmacotherapy
Vol 3 , 2023 | Kumutha Theivasigamani
Comparative Evaluation of Oral Wound Dressing Materials: A Comprehensive Clinical Review
Annals of Pharmacy Practice and Pharmacotherapy
Vol 4 , 2024 | Maria Pia Ferraz
Development of an RP-HPLC Method for Dapagliflozin and Metformin HCL Analysis
Annals of Pharmacy Practice and Pharmacotherapy
Vol 1 , 2021 | Khagga Bhavyasri
Development of a Customizable, Near Real-Time TEER System for Dynamic Barrier Function Analysis
Annals of Pharmacy Practice and Pharmacotherapy
Vol 1 , 2021 | Ahmed A. Al-Harbi
Analysis of Spontaneous Reports of Psychiatric Adverse Events Associated with GLP-1 Analogues
Annals of Pharmacy Practice and Pharmacotherapy
Vol 2 , 2022 | Piotr Kowalski
PPAR-γ Deubiquitination Mediates the Anti-Senescent Effects of 1, 8-Cineole in Diabetic Vasculature
Annals of Pharmacy Practice and Pharmacotherapy
Vol 2 , 2022 | Andrew J. Collins

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.